TANGYI HOLDINGS (SHENZHEN) CO LTD
Overview
TANGYI HOLDINGS (SHENZHEN) CO LTD is an active pharmaceutical ingredient (API) supplier with 1 active FDA Type II Drug Master File, covering EXOSOMES OF HUMAN UMBILICAL CORD MESENCHYMAL STEM CELLS.
API / Drug Master Files
TANGYI HOLDINGS (SHENZHEN) CO LTD holds 1 active (1 total) FDA Type II Drug Master File — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- EXOSOMES OF HUMAN UMBILICAL CORD MESENCHYMAL STEM CELLSActive2023-12-29
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to TANGYI HOLDINGS (SHENZHEN) CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this TANGYI HOLDINGS (SHENZHEN) CO LTD? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.